Ask Our Doctors and Nurses!

ALPRAZOLAM Side Effect?
Don't put Your Health at Risk - Take Action Now! Type your question here

 letters left

ALPRAZOLAM Safety Reports

Total ALPRAZOLAM reports: 230.
ALPRAZOLAM FDA safety alerts: 2002 2007 .
Reported deaths: 62    Reported hospitalizations: 86.
Take ALPRAZOLAM Side Effects Survey or Share Your ALPRAZOLAM Story. Read More Here.

Showing 1-75 of 230 Next >

Health Professional from JAPAN reported ALPRAZOLAM problem on Sept 04, 2006. Female patient, 37 years of age, was treated with ALPRAZOLAM. After drug was administered, patient experienced the following problems/side effects: electrocardiogram abnormal, overdose, suicide attempt. ALPRAZOLAM dosage: unknown. Patient recovered.

ALPRAZOLAM problem was reported by a Health Professional from JAPAN on Sept 04, 2006. Male patient, 33 years of age, was treated with ALPRAZOLAM. After drug was administered, patient experienced the following problems/side effects: agitation, coma, suicide attempt. ALPRAZOLAM dosage: unknown. Patient recovered.

Health Professional from JAPAN reported ALPRAZOLAM problem on Sept 04, 2006. Female patient, child 3 years of age, was treated with ALPRAZOLAM. After drug was administered, patient experienced the following problems/side effects: coma. ALPRAZOLAM dosage: unknown. Patient recovered.

ALPRAZOLAM problem was reported by a Consumer or non-health professional from JAPAN on Sept 15, 2006. Male patient, 74 years of age, was diagnosed with major depression and was treated with ALPRAZOLAM. After drug was administered, patient experienced the following problems/side effects: blood pressure fluctuation, cerebral atrophy, disorientation, extrapyramidal disorder, heart rate increased, neuroleptic malignant syndrome, psychomotor retardation, white blood cell count increased. ALPRAZOLAM dosage: 1.2MG - QD. During the same period patient was treated with PAROXETINE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from BRAZIL reported ALPRAZOLAM problem on Sept 14, 2006. Female patient, 71 years of age, was diagnosed with anxiety, depression and was treated with ALPRAZOLAM. After drug was administered, patient experienced the following problems/side effects: bladder prolapse, rectal prolapse, uterine prolapse. ALPRAZOLAM dosage: 2.5 MG (0.5 MG, 5 IN 1 D); ORAL. During the same period patient was treated with MELLARIL, AKINETON, PIPORTIL. Patient recovered.

ALPRAZOLAM problem was reported by a Physician from UNITED STATES on Sept 14, 2006. Female patient, 43 years of age, was treated with ALPRAZOLAM. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, completed suicide, respiratory arrest. ALPRAZOLAM dosage: (0.5 MG), ORAL. During the same period patient was treated with METHADONE, MORPHINE, DYAZIDE, IBUPROFEN, DEXTROAMPHETAMINE. Patient died.

Pharmacist from JAPAN reported ALPRAZOLAM problem on Sept 14, 2006. Female patient was treated with ALPRAZOLAM. After drug was administered, patient experienced the following problems/side effects: pancreatitis. ALPRAZOLAM dosage: unknown. Patient recovered.

ALPRAZOLAM problem was reported by a Consumer or non-health professional from BRAZIL on Sept 19, 2006. Male patient was diagnosed with insomnia and was treated with ALPRAZOLAM. After drug was administered, patient experienced the following problems/side effects: headache, intentional overdose, irritability, malaise. ALPRAZOLAM dosage: 1 MG (1 MG, 1 IN 1 D), ORAL. Patient recovered.

Consumer or non-health professional from BRAZIL reported ALPRAZOLAM problem on Sept 19, 2006. Female patient, 29 years of age, was diagnosed with anxiety, depression and was treated with ALPRAZOLAM. After drug was administered, patient experienced the following problems/side effects: abdominal distension, alopecia, amnesia, anxiety, arthralgia, asthenia, back pain, burning sensation, condition aggravated. ALPRAZOLAM dosage: 0.5 MG (0.5 MG, 1 IN 1 D), ORAL. During the same period patient was treated with OMEPRAZOLE, FLUOXETINE, LEVONORGESTREL, PAROXETINE, LEVONORGESTREL W, ETHINYL ESTRADIOL, DEPAKENE. Patient was hospitalized. Patient recovered.

ALPRAZOLAM problem was reported by a Consumer or non-health professional from BRAZIL on Sept 28, 2006. Female patient, 46 years of age, was diagnosed with panic reaction, toothache and was treated with ALPRAZOLAM. After drug was administered, patient experienced the following problems/side effects: amputation, iatrogenic injury, implant site inflammation, meniscus lesion, toothache. ALPRAZOLAM dosage: 2 MG (2 MG, 1 IN 1 D), ORAL. During the same period patient was treated with CELEBREX. Patient was hospitalized and became disabled. Patient recovered.

Consumer or non-health professional from BRAZIL reported ALPRAZOLAM problem on Sept 27, 2006. Male patient, 70 years of age, was diagnosed with anxiety, depression, pharyngitis and was treated with ALPRAZOLAM. After drug was administered, patient experienced the following problems/side effects: dry eye, eye irritation, gastritis, hypertension, incorrect dose administered, oesophageal pain, pharyngitis, thyroid cyst. ALPRAZOLAM dosage: 0.25 MG (0.25 MG, 1 IN 1 D); ORAL. During the same period patient was treated with CEPHALEXIN, AMOXICILLIN, DICLOFENAC, PAROXETINE. Patient recovered.

ALPRAZOLAM problem was reported by a Physician from SWEDEN on May 30, 2005. Male patient, 60 years of age, was diagnosed with ill-defined disorder, menopausal symptoms and was treated with ALPRAZOLAM. After drug was administered, patient experienced the following problems/side effects: arteriosclerosis, malignant urinary tract neoplasm, renal oncocytoma, venous thrombosis. ALPRAZOLAM dosage: 1 MG, ORAL. During the same period patient was treated with ZOPICLONE, NOZINAN, KLIOGEST, CARBAMAZEPINE, REMERON, SPIRIVA, BUVENTOL. Patient died on 01/25/2005.

Consumer or non-health professional from BRAZIL reported ALPRAZOLAM problem on Oct 02, 2006. Female patient, 47 years of age, was diagnosed with insomnia and was treated with ALPRAZOLAM. After drug was administered, patient experienced the following problems/side effects: cholecystectomy. ALPRAZOLAM dosage: 0.5 MG (0.5 MG, AS NECESSARY) ORAL. During the same period patient was treated with OMEPRAZOLE. Patient was hospitalized. Patient recovered.

ALPRAZOLAM problem was reported by a Consumer or non-health professional from BRAZIL on Oct 02, 2006. Male patient was diagnosed with anxiety and was treated with ALPRAZOLAM. After drug was administered, patient experienced the following problems/side effects: resorption bone increased, tooth disorder, tooth fracture. ALPRAZOLAM dosage: 0.25 MG (0.125 MG, 2 IN 1 D), ORAL. Patient recovered.

Health Professional from UNITED STATES reported ALPRAZOLAM problem on Oct 04, 2006. Female patient, 43 years of age, weighting 174.0 lb, was diagnosed with anxiety disorder and was treated with ALPRAZOLAM. After drug was administered, patient experienced the following problems/side effects: blood glucose increased, blood sodium decreased, blood triglycerides increased, carbon dioxide decreased, flushing, haemoglobin increased, heart rate increased, high density lipoprotein decreased, red blood cell count increased. ALPRAZOLAM dosage: 0.5 MG (0.25 MG, 2 IN 1 D). During the same period patient was treated with PROPRANOLOL, SPIRONOLACTONE, NEXIUM, ANTIBIOTICS. Patient recovered.

ALPRAZOLAM problem was reported by a Consumer or non-health professional from JAPAN on Oct 03, 2006. Male patient, 74 years of age, was diagnosed with major depression and was treated with ALPRAZOLAM. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood urea increased, cerebral atrophy, dehydration, extrapyramidal disorder, malnutrition, neuroleptic malignant syndrome, psychomotor retardation. ALPRAZOLAM dosage: 1.2 MG (1 D). During the same period patient was treated with PAROXETINE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from BRAZIL reported ALPRAZOLAM problem on Oct 03, 2006. Female patient, 29 years of age, was diagnosed with anxiety, depression, gastritis and was treated with ALPRAZOLAM. After drug was administered, patient experienced the following problems/side effects: abdominal distension, abdominal pain upper, abnormal behaviour, abnormal dreams, alopecia, amnesia, anxiety, arthralgia, asthenia. ALPRAZOLAM dosage: 0.5 MG (0..5 MG, 1 IN 1 D); ORAL (SEE IMAGE). During the same period patient was treated with DEPAKENE, OMEPRAZOLE, FLUOXETINE, LEVONORGESTREL, PAROXETINE. Patient was hospitalized. Patient recovered.

ALPRAZOLAM problem was reported by a Consumer or non-health professional from BRAZIL on Oct 09, 2006. Female patient, 46 years of age, was diagnosed with insomnia and was treated with ALPRAZOLAM. After drug was administered, patient experienced the following problems/side effects: anorexia, asthenia, depression, nausea, stomach discomfort, urinary tract infection, uterine leiomyoma. ALPRAZOLAM dosage: 0.5 MG (0.5 MG, AS NEEDED), ORAL. During the same period patient was treated with NITROFURANTOIN, OMEPRAZOLE. Patient was hospitalized and became disabled. Patient recovered.

Consumer or non-health professional from BRAZIL reported ALPRAZOLAM problem on Oct 09, 2006. Female patient, 29 years of age, was diagnosed with anxiety, depression, gastritis and was treated with ALPRAZOLAM. After drug was administered, patient experienced the following problems/side effects: abnormal dreams, alcohol use, alopecia, amnesia, anxiety, arthralgia, asthenia, back pain, condition aggravated. ALPRAZOLAM dosage: 0.5 MG (0.5 MG, 1 IN 1 D), ORAL. During the same period patient was treated with DEPAKENE, OMEPRAZOLE, FLUOXETINE, LEVONORGESTREL, PAROXETINE. Patient was hospitalized. Patient recovered.

ALPRAZOLAM problem was reported by a Consumer or non-health professional from BRAZIL on Oct 09, 2006. Female patient, 45 years of age, was diagnosed with insomnia and was treated with ALPRAZOLAM. After drug was administered, patient experienced the following problems/side effects: cholelithiasis, pancreatitis. ALPRAZOLAM dosage: 0.5 MG (0.5 MG, AS NECESSARY), ORAL. During the same period patient was treated with OMEPRAZOLE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from BRAZIL reported ALPRAZOLAM problem on Oct 16, 2006. Female patient, 37 years of age, was diagnosed with sleep disorder and was treated with ALPRAZOLAM. After drug was administered, patient experienced the following problems/side effects: abdominal hernia, breast operation, muscular weakness, rash maculo-papular, rash pruritic. ALPRAZOLAM dosage: 0.25 MG (0.25 MG, 1 IN 1 D) ORAL. During the same period patient was treated with ACETAMINOPHEN. Patient was hospitalized. Patient recovered.

ALPRAZOLAM problem was reported by a Pharmacist from JAPAN on Oct 17, 2006. Female patient was treated with ALPRAZOLAM. After drug was administered, patient experienced the following problems/side effects: cataract. ALPRAZOLAM dosage: unknown. Patient recovered.

Consumer or non-health professional from BRAZIL reported ALPRAZOLAM problem on Oct 16, 2006. Female patient, 87 years of age, weighting 63.93 lb, was diagnosed with anxiety and was treated with ALPRAZOLAM. After drug was administered, patient experienced the following problems/side effects: anorexia, asthenia, blood pressure decreased, dyspnoea, dysstasia, insomnia, pain in extremity, sedation, somnolence. ALPRAZOLAM dosage: 0.5 MG (0.5 MG, 1 IN 1 D), ORAL. During the same period patient was treated with AMLODIPINE, LAXATIVES, ZINC. Patient recovered.

ALPRAZOLAM problem was reported by a Consumer or non-health professional from BRAZIL on Oct 18, 2006. Female patient, 87 years of age, weighting 63.93 lb, was diagnosed with anxiety and was treated with ALPRAZOLAM. After drug was administered, patient experienced the following problems/side effects: anorexia, asthenia, blood pressure decreased, dyspnoea, dysstasia, fatigue, gait disturbance, pain in extremity, sedation. ALPRAZOLAM dosage: 0.25 MG (0.25 MG, 1 IN 1 D), ORAL. During the same period patient was treated with AMLODIPINE, LAXATIVES, ZINC. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ALPRAZOLAM problem on Nov 01, 2006. Male patient, 45 years of age, weighting 210.0 lb, was treated with ALPRAZOLAM. After drug was administered, patient experienced the following problems/side effects: economic problem. ALPRAZOLAM dosage: unknown. Patient recovered.

ALPRAZOLAM problem was reported by a Consumer or non-health professional from BRAZIL on Oct 23, 2006. Male patient was diagnosed with anxiety, stress and was treated with ALPRAZOLAM. After drug was administered, patient experienced the following problems/side effects: arterial occlusive disease, blood pressure increased, fear of disease, headache, stress. ALPRAZOLAM dosage: 1 MG (1 MG, 1 IN 1 D), ORAL. During the same period patient was treated with LIPITOR, ENALAPRIL MALEATE. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ALPRAZOLAM problem on Oct 24, 2006. Male patient, 13 years of age, weighting 125.0 lb, was diagnosed with depression and was treated with ALPRAZOLAM. After drug was administered, patient experienced the following problems/side effects: monoparesis, sciatic nerve injury, treatment noncompliance. ALPRAZOLAM dosage: 0.5 MG (0.5 MG, 1 IN 1 D). Patient was hospitalized. Patient recovered.

ALPRAZOLAM problem was reported by a Pharmacist from JAPAN on Oct 25, 2006. Male patient, 60 years of age, was diagnosed with suicide attempt and was treated with ALPRAZOLAM. After drug was administered, patient experienced the following problems/side effects: blood cholinesterase decreased, faecal incontinence, overdose, skin laceration, suicide attempt, urinary incontinence. ALPRAZOLAM dosage: unknown. During the same period patient was treated with AMOBAN, URSO, TAMBOCOR. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ALPRAZOLAM problem on Nov 14, 2006. Female patient, 77 years of age, was treated with ALPRAZOLAM. After drug was administered, patient experienced the following problems/side effects: incorrect dose administered, somnolence. ALPRAZOLAM dosage: 0.5 MG TABLET 1000 CT. BOTTLE. Patient recovered.

ALPRAZOLAM problem was reported by a Consumer or non-health professional from BRAZIL on Nov 01, 2006. Female patient, 46 years of age, was diagnosed with panic reaction, toothache and was treated with ALPRAZOLAM. After drug was administered, patient experienced the following problems/side effects: arthritis, iatrogenic injury, inflammation, leg amputation, meniscus lesion, toothache. ALPRAZOLAM dosage: 2 MG (1 MG, 2 IN 1 D), ORAL. During the same period patient was treated with CELEBREX, DIOVAN HCT, GLUCOVANCE. Patient was hospitalized and became disabled. Patient recovered.

Physician from JAPAN reported ALPRAZOLAM problem on Nov 01, 2006. Male patient, 60 years of age, weighting 113.3 lb, was diagnosed with suicide attempt and was treated with ALPRAZOLAM. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood cholinesterase decreased, contusion, faecal incontinence, fall, gamma-glutamyltransferase increased, intentional self-injury, laceration. ALPRAZOLAM dosage: unknown. During the same period patient was treated with AMOBAN, URSO, TAMBOCOR, METHYCOBAL, EPADEL, SOLON, ACTOS, STRONG NEO MINOPHAGEN C. Patient was hospitalized. Patient recovered.

ALPRAZOLAM problem was reported by a Physician from COSTA RICA on Nov 07, 2006. Female patient, 49 years of age, was diagnosed with anxiety and was treated with ALPRAZOLAM. After drug was administered, patient experienced the following problems/side effects: bronchospasm, dermatitis allergic. ALPRAZOLAM dosage: 1 MG (1 MG, 1 IN 1 D), ORAL. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ALPRAZOLAM problem on Nov 07, 2006. Male patient, weighting 200.0 lb, was diagnosed with anxiety, panic attack, bipolar i disorder and was treated with ALPRAZOLAM. After drug was administered, patient experienced the following problems/side effects: cervical vertebral fracture, coma, convulsion, head injury, loss of consciousness, memory impairment, road traffic accident, spinal fracture, weight decreased. ALPRAZOLAM dosage: 3 MG (1 MG, 3 IN 1 D). During the same period patient was treated with ZOLOFT, LORTAB, FLEXERIL. Patient was hospitalized. Patient recovered.

ALPRAZOLAM problem was reported by a Pharmacist from JAPAN on Nov 10, 2006. Female patient, 43 years of age, was treated with ALPRAZOLAM. After drug was administered, patient experienced the following problems/side effects: delusion, tremor. ALPRAZOLAM dosage: 1.2 MG, ORAL. During the same period patient was treated with DOGMATYL, DEPAS, ZOLPIDEM TARTRATE, TOLEDOMIN. Patient recovered.

Consumer or non-health professional from BRAZIL reported ALPRAZOLAM problem on Nov 10, 2006. Female patient, 37 years of age, was diagnosed with sleep disorder and was treated with ALPRAZOLAM. After drug was administered, patient experienced the following problems/side effects: abdominal hernia repair, erythema, hypersensitivity, hysterectomy, incisional hernia, mastectomy, muscular weakness, nodule. ALPRAZOLAM dosage: 0.25 MG (0.25 MG, 1 IN 1 D), ORAL. During the same period patient was treated with TYLENOL, PIROXICAM. Patient was hospitalized. Patient recovered.

ALPRAZOLAM problem was reported by a Physician from UNITED STATES on Nov 09, 2006. Female patient, 44 years of age, was treated with ALPRAZOLAM. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, completed suicide, respiratory arrest. ALPRAZOLAM dosage: unknown. During the same period patient was treated with QUETIAPINE FUMARATE. Patient died on 01/01/2005.

Physician from UNITED STATES reported ALPRAZOLAM problem on Nov 09, 2006. Female patient, 49 years of age, was treated with ALPRAZOLAM. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, respiratory arrest. ALPRAZOLAM dosage: unknown. During the same period patient was treated with FENTANYL, HYDROCODONE BITARTRATE. Patient died on 01/01/2005.

ALPRAZOLAM problem was reported by a Physician from UNITED STATES on Nov 09, 2006. Female patient, 48 years of age, was treated with ALPRAZOLAM. After drug was administered, patient experienced the following problems/side effects: completed suicide. ALPRAZOLAM dosage: unknown. During the same period patient was treated with TRAZODONE. Patient died on 01/01/2005.

Physician from UNITED STATES reported ALPRAZOLAM problem on Nov 09, 2006. Female patient, 43 years of age, was treated with ALPRAZOLAM. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, completed suicide, respiratory arrest. ALPRAZOLAM dosage: unknown. During the same period patient was treated with CODEINE SUL, ZOLPIDEM TARTRATE. Patient died on 01/01/2005.

ALPRAZOLAM problem was reported by a Physician from UNITED STATES on Nov 28, 2006. Female patient was diagnosed with major depression and was treated with ALPRAZOLAM. After drug was administered, patient experienced the following problems/side effects: anxiety. ALPRAZOLAM dosage: 0.5 MG 2-3 X/ DAY. Patient recovered.

Physician from UNITED STATES reported ALPRAZOLAM problem on Nov 09, 2006. Female patient, 39 years of age, was treated with ALPRAZOLAM. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, completed suicide, respiratory arrest. ALPRAZOLAM dosage: unknown. During the same period patient was treated with ESCITALOPRAM OXALATE, CHLORPHENIRAMINE MALEATE. Patient died on 01/01/2005.

ALPRAZOLAM problem was reported by a Physician from UNITED STATES on Nov 09, 2006. Female patient, 32 years of age, was treated with ALPRAZOLAM. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, respiratory arrest. ALPRAZOLAM dosage: unknown. During the same period patient was treated with VENLAFAXIINE, HYDROCODONE BITARTRATE. Patient died on 01/01/2005.

Physician from UNITED STATES reported ALPRAZOLAM problem on Nov 09, 2006. Female patient, 43 years of age, was treated with ALPRAZOLAM. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, completed suicide, respiratory arrest. ALPRAZOLAM dosage: unknown. During the same period patient was treated with MORPHINE, IBUPROFEN, DEXTROAMPETAMINE SULPHATE, METHADONE HYDROCHLORIDE, DYAZIDE. Patient died on 01/01/2005.

ALPRAZOLAM problem was reported by a Physician from UNITED STATES on Nov 09, 2006. Female patient, 37 years of age, was treated with ALPRAZOLAM. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, completed suicide, respiratory arrest. ALPRAZOLAM dosage: unknown. During the same period patient was treated with CHLORAL HYDRATE. Patient died on 01/01/2005.

Physician from UNITED STATES reported ALPRAZOLAM problem on Nov 09, 2006. Female patient, 47 years of age, was treated with ALPRAZOLAM. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, completed suicide, respiratory arrest. ALPRAZOLAM dosage: unknown. Patient died on 01/01/2005.

ALPRAZOLAM problem was reported by a Physician from UNITED STATES on Nov 09, 2006. Female patient, 24 years of age, was treated with ALPRAZOLAM. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, completed suicide, respiratory arrest. ALPRAZOLAM dosage: unknown. During the same period patient was treated with METHADONE, COCAINE. Patient died on 01/01/2005.

Physician from UNITED STATES reported ALPRAZOLAM problem on Nov 09, 2006. Female patient, 35 years of age, was treated with ALPRAZOLAM. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, completed suicide, respiratory arrest. ALPRAZOLAM dosage: unknown. During the same period patient was treated with MIRTAZAPINE, ACETAMINOPHEN AND OXYCODONE. Patient died on 01/01/2005.

ALPRAZOLAM problem was reported by a Physician from UNITED STATES on Nov 09, 2006. Female patient, 48 years of age, was treated with ALPRAZOLAM. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, respiratory arrest. ALPRAZOLAM dosage: unknown. During the same period patient was treated with METHADONE. Patient died on 01/01/2005.

Physician from UNITED STATES reported ALPRAZOLAM problem on Nov 09, 2006. Female patient, 44 years of age, was treated with ALPRAZOLAM. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, respiratory arrest. ALPRAZOLAM dosage: unknown. During the same period patient was treated with METHADONE, OXYCODONE. Patient died on 01/01/2005.

ALPRAZOLAM problem was reported by a Physician from UNITED STATES on Nov 09, 2006. Female patient, 55 years of age, was treated with ALPRAZOLAM. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, completed suicide, respiratory arrest. ALPRAZOLAM dosage: unknown. During the same period patient was treated with CARISOPRODOL. Patient died on 01/01/2005.

Physician from UNITED STATES reported ALPRAZOLAM problem on Nov 09, 2006. Female patient, 29 years of age, was treated with ALPRAZOLAM. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, respiratory arrest. ALPRAZOLAM dosage: unknown. During the same period patient was treated with METHADONE, ESCITALOPRAM OXALATE. Patient died on 01/01/2005.

ALPRAZOLAM problem was reported by a Physician from UNITED STATES on Nov 09, 2006. Female patient, 66 years of age, was treated with ALPRAZOLAM. After drug was administered, patient experienced the following problems/side effects: completed suicide. ALPRAZOLAM dosage: unknown. During the same period patient was treated with CHLORPROMAZINE, BUPROPION. Patient died on 01/01/2005.

Physician from UNITED STATES reported ALPRAZOLAM problem on Nov 09, 2006. Female patient, 29 years of age, was treated with ALPRAZOLAM. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, respiratory arrest. ALPRAZOLAM dosage: unknown. During the same period patient was treated with METHADONE, ESCITALOPRAM OXALATE. Patient died on 01/01/2005.

ALPRAZOLAM problem was reported by a Physician from UNITED STATES on Nov 09, 2006. Female patient, 34 years of age, was treated with ALPRAZOLAM. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, respiratory arrest. ALPRAZOLAM dosage: unknown. During the same period patient was treated with METHADONE, PROMETHAZINE. Patient died on 01/01/2005.

Physician from UNITED STATES reported ALPRAZOLAM problem on Nov 09, 2006. Female patient, 24 years of age, was treated with ALPRAZOLAM. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, completed suicide, respiratory arrest. ALPRAZOLAM dosage: unknown. During the same period patient was treated with OXYCODONE, HYDROCODONE BITARTRATE. Patient died on 01/01/2005.

ALPRAZOLAM problem was reported by a Physician from UNITED STATES on Nov 09, 2006. Female patient, 21 years of age, was treated with ALPRAZOLAM. ALPRAZOLAM dosage: unknown. During the same period patient was treated with DIAZEPAM, OXYCODONE. Patient died on 01/01/2005.

Physician from UNITED STATES reported ALPRAZOLAM problem on Nov 09, 2006. Female patient, 33 years of age, was treated with ALPRAZOLAM. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, respiratory arrest. ALPRAZOLAM dosage: unknown. During the same period patient was treated with HYDROCODONE, METHADONE. Patient died on 01/01/2005.

ALPRAZOLAM problem was reported by a Physician from UNITED STATES on Nov 09, 2006. Female patient, 56 years of age, was treated with ALPRAZOLAM. After drug was administered, patient experienced the following problems/side effects: completed suicide. ALPRAZOLAM dosage: unknown. Patient died on 01/01/2005.

Physician from UNITED STATES reported ALPRAZOLAM problem on Nov 09, 2006. Female patient, 52 years of age, was treated with ALPRAZOLAM. After drug was administered, patient experienced the following problems/side effects: completed suicide, exposure to toxic agent. ALPRAZOLAM dosage: unknown. During the same period patient was treated with TRAZODONE, ACETAMINOPHEN. Patient died on 01/01/2005.

ALPRAZOLAM problem was reported by a Physician from UNITED STATES on Nov 09, 2006. Female patient, 49 years of age, was treated with ALPRAZOLAM. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, respiratory arrest. ALPRAZOLAM dosage: unknown. During the same period patient was treated with FENTANYL, HYDROCODONE W. Patient died on 01/01/2005.

Physician from UNITED STATES reported ALPRAZOLAM problem on Nov 09, 2006. Female patient, 48 years of age, was treated with ALPRAZOLAM. After drug was administered, patient experienced the following problems/side effects: completed suicide. ALPRAZOLAM dosage: unknown. During the same period patient was treated with TRAZODONE. Patient died on 01/01/2005.

ALPRAZOLAM problem was reported by a Physician from UNITED STATES on Nov 09, 2006. Female patient, 45 years of age, was treated with ALPRAZOLAM. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, respiratory arrest. ALPRAZOLAM dosage: unknown. During the same period patient was treated with METHADONE, OLANZAPINE. Patient died on 01/01/2005.

Physician from UNITED STATES reported ALPRAZOLAM problem on Nov 09, 2006. Female patient, 52 years of age, was treated with ALPRAZOLAM. After drug was administered, patient experienced the following problems/side effects: completed suicide. ALPRAZOLAM dosage: unknown. During the same period patient was treated with TRAZODONE, ACETAMINOPHEN. Patient died on 01/01/2005.

ALPRAZOLAM problem was reported by a Physician from UNITED STATES on Nov 09, 2006. Female patient, 31 years of age, was treated with ALPRAZOLAM. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, respiratory arrest. ALPRAZOLAM dosage: unknown. During the same period patient was treated with MORPHINE, TEMAZEPAM. Patient died on 01/01/2005.

Physician from UNITED STATES reported ALPRAZOLAM problem on Nov 09, 2006. Female patient, 17 years of age, was treated with ALPRAZOLAM. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, respiratory arrest. ALPRAZOLAM dosage: unknown. During the same period patient was treated with METHAMPHETAMINE, ACETAMINOPHEN AND HYDROCODONE BITARTRATE. Patient died on 01/01/2005.

ALPRAZOLAM problem was reported by a Physician from UNITED STATES on Nov 09, 2006. Female patient, 50 years of age, was treated with ALPRAZOLAM. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, completed suicide, respiratory arrest. ALPRAZOLAM dosage: unknown. During the same period patient was treated with CARBON MONOXIDE, PROPOXYPHENE. Patient died on 01/01/2005.

Physician from UNITED STATES reported ALPRAZOLAM problem on Nov 09, 2006. Female patient, 18 years of age, was treated with ALPRAZOLAM. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, respiratory arrest. ALPRAZOLAM dosage: unknown. During the same period patient was treated with METHADONE, COCAINE. Patient died on 01/01/2005.

ALPRAZOLAM problem was reported by a Physician from UNITED STATES on Nov 09, 2006. Female patient, 33 years of age, was treated with ALPRAZOLAM. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, respiratory arrest. ALPRAZOLAM dosage: unknown. During the same period patient was treated with METHADONE. Patient died on 01/01/2005.

Physician from UNITED STATES reported ALPRAZOLAM problem on Nov 09, 2006. Female patient, 41 years of age, was treated with ALPRAZOLAM. After drug was administered, patient experienced the following problems/side effects: completed suicide. ALPRAZOLAM dosage: unknown. During the same period patient was treated with ETHYLENE GLYCOL. Patient died on 01/01/2005.

ALPRAZOLAM problem was reported by a Physician from UNITED STATES on Nov 09, 2006. Female patient, 34 years of age, was treated with ALPRAZOLAM. After drug was administered, patient experienced the following problems/side effects: completed suicide. ALPRAZOLAM dosage: unknown. During the same period patient was treated with TRICYCLIC ANTIDEPRESSANTS, ESCITALOPRAM OXALATE. Patient died on 01/01/2005.

Physician from UNITED STATES reported ALPRAZOLAM problem on Nov 09, 2006. Female patient, 45 years of age, was treated with ALPRAZOLAM. After drug was administered, patient experienced the following problems/side effects: completed suicide. ALPRAZOLAM dosage: unknown. During the same period patient was treated with METHADONE, OXYCODONE. Patient died on 01/01/2005.

ALPRAZOLAM problem was reported by a Physician from UNITED STATES on Nov 09, 2006. Female patient, 31 years of age, was treated with ALPRAZOLAM. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, respiratory arrest. ALPRAZOLAM dosage: unknown. During the same period patient was treated with NORTRIPTYLINE, METHADONE. Patient died on 01/01/2005.

Physician from UNITED STATES reported ALPRAZOLAM problem on Nov 09, 2006. Female patient, 28 years of age, was treated with ALPRAZOLAM. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, exposure to toxic agent, respiratory arrest. ALPRAZOLAM dosage: unknown. During the same period patient was treated with ETHANOL, METHADONE. Patient died on 01/01/2005.

ALPRAZOLAM problem was reported by a Physician from UNITED STATES on Nov 09, 2006. Female patient, 21 years of age, was treated with ALPRAZOLAM. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, respiratory arrest. ALPRAZOLAM dosage: unknown. During the same period patient was treated with HYDROCODONE BITARTRATE. Patient died on 01/01/2005.

Physician from UNITED STATES reported ALPRAZOLAM problem on Nov 09, 2006. Female patient, 18 years of age, was treated with ALPRAZOLAM. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, respiratory arrest. ALPRAZOLAM dosage: unknown. During the same period patient was treated with HYDROCODONE BITARTRATE, METHADONE. Patient died on 01/01/2005.

Showing 1-75 of 230 Next >